BillionaireNet
family
Christine Franken & family
Rank #2108
GERMANYHealthcareBiopharmaceuticals

Christine Franken & family

Net Worth
$1.832B
+0.38% (24h)
Christine Franken, at 80 years old, is a prominent figure in the biopharmaceuticals industry, with a net worth of $1.9 billion. Her wealth stems from her family's significant stake in Sartorius AG, a leading manufacturer of pharmaceutical and laboratory equipment. Franken's career and influence highlight the impact of long-term investments in the healthcare sector. Her story reflects strategic financial planning and a commitment to innovation within the biopharmaceutical realm.

The Full Dossier

Early Life

Information regarding Christine Franken's early life and education is limited. However, it's known that she is one of the three daughters of Horst Sartorius, who passed on a 50% stake in the biopharmaceutical firm Sartorius AG after his death in 1998.

Rise to Success

The Franken family's wealth is primarily derived from their stake in Sartorius AG. The company was founded in 1870 by Florenz Sartorius to make analytical balances. Sartorius AG went public in 1990 and has since become a significant player in the pharmaceutical and laboratory equipment sector.

Key Business Strategies

Sartorius AG's success is based on its focus on pharmaceutical and laboratory equipment. The company's annual revenue exceeds $2.5 billion, and it employs approximately 10,600 people. This focus and the legacy of its founding have been key strategies to its success.

Philanthropy

Information regarding Christine Franken's specific philanthropic activities is unavailable. However, as a member of a wealthy family, it's likely she supports various charitable causes.

Career Timeline

1998

Inheritance of Sartorius AG stake

Received a share of her father's 50% stake in Sartorius AG upon his death.

Wealth Trajectory